NEW YORK CITY, NY / ACCESS Newswire / September 29, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ:SLNO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Soleno and certain of its officers and/or […]
NEW YORK CITY, NY / ACCESS Newswire / September 29, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Axogen, Inc. ("Axogen" or the "Company") (NASDAQ:AXGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Axogen and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / September 29, 2025 / If you suffered a loss on your V.F. Corporation (NYSE:VFC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/v-f-corporation-lawsuit-submission-form?prid=170037&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
The joint showcase at Fiserv Forum Client Conference Sep. 29-30, 2025, highlights new solutions to reduce manual effort, strengthen governance and improve customer experiences OpenText™ (NASDAQ: OTEX, TSX: OTEX), a global leader in secure information management for AI, and Fiserv, Inc., a global leader in payments and financial technology, today announced Content Next, a specialized,
NEW YORK, NY / ACCESS Newswire / September 29, 2025 / If you suffered a loss on your Semler Scientific, Inc. (NASDAQ:SMLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/semler-scientific-inc-lawsuit-submission-form?prid=170035&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / September 29, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Coty Inc. ("Coty" or the "Company") (NYSE:COTY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Coty and certain of its officers and/or directors have
NEW YORK CITY, NY / ACCESS Newswire / September 29, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Axogen, Inc. ("Axogen" or the "Company") (NASDAQ:AXGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Axogen and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / September 29, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Coty Inc. ("Coty" or the "Company") (NYSE:COTY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Coty and certain of its officers and/or directors have
NEW YORK CITY, NY / ACCESS Newswire / September 29, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ:SLNO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Soleno and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / September 29, 2025 / If you suffered a loss on your V.F. Corporation (NYSE:VFC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/v-f-corporation-lawsuit-submission-form?prid=170037&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call